+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Interbody Fusion Cage Market by Product Type, Surgery, and End User : Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 270 Pages
  • February 2022
  • Region: Global
  • Allied Market Research
  • ID: 5578247
The global interbody fusion cages market was valued at $ 1,901.67 million in 2020, and is projected to reach $ 3,012.47 million by 2030, registering a CAGR of 4.7% from 2021 to 2030.

Interbody fusion cage is an artificial medical device, which is utilized in spinal fusion procedures to maintain foraminal height and decompression. The interbody fusion cage is a large, hollow cylinder made up of metals such as titanium, carbon fiber, or allograft femur. The device is designed as a cage so that bone graft can be placed inside the hollow cylinder to allow a spinal fusion to occur between two vertebrae. Interbody fusion cage utilized to provide stability to the spine and the cervical region. The cages can be filled with autologous bone material to promote arthrodesis (artificial induction of joint ossification).

The key factors that drive the market growth are rise in geriatric population and increase in spinal cord injuries, which might be caused due to accidents and diseases such as degenerative disk disease. However, high cost associated with spinal fusion surgeries and dearth of skilled professionals are anticipated to impede the growth of interbody fusion cage market. On the contrary, increased adoption of minimally invasive surgeries is projected to create ample opportunities in the market.

The interbody fusion cages market is segmented into product type, surgery, end user, and region. By product type, the market is segregated into lumbar cage, cervical cage, thoraco-lumbar cage, and thoracic cage. On the basis of surgery, it is fragmented into anterior, posterior, lateral, and transforaminal. Depending on end user, it is fragmented into hospitals & clinics, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA).

The major companies profiled in the report include Aurora Spine, Inc, B. Braun Melsungen AG, Benvenue Medical Inc., Prodorth, Ulrich Medicals, Orthofix, Medtronic Plc., Zimmer Biomet Holdings, Inc., NuVasive, Inc., and Johnson & Johnson.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global interbody fusion cage market with current trends and future estimations to elucidate the imminent investment pockets
  • Comprehensive quantitative analysis of the industry from 2021 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities
  • Extensive analysis of the key segments of the industry helps to understand the products and technologies used globally
  • Key market players and their strategies are provided to understand the competitive outlook of the market

By Product Type

  • Lumbar Cage
  • Cervical Cage
  • Thoraco-lumbar Cage
  • Thoracic Cage

By Surgery

  • Anterior
  • Posterior
  • Lateral
  • Transforaminal

By End User

  • Hospital & Clinics
  • Others
  • Ambulatory Surgical Center

By Region

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY PLAYERS

  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim
  • GNI Group Ltd
  • F. Hoffmann-La Roche Ltd (Genentech, Inc,)
  • Shiongi co Ltd
  • Mission Therapeutics
  • Biogen, Inc
  • Galapagos NV
  • FibroGen, Inc

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

Chapter 1: Introduction
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
Chapter 2: Executive Summary
2.1. Cxo Perspective
Chapter 3: Market Landscape
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power Among Buyers
3.4. Market Share Analysis/Top Player Positioning
3.4.1. Market Share Analysis/Top Player Positioning 2020
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. Covid-19 Impact Analysis
Chapter 4: Interbody Fusion Cages Market, by Product
4.1. Market Overview
4.1.1Market Size and Forecast, by Product
4.2. Lumbar
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Share Analysis, by Country
4.3. Cervical
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, by Region
4.3.3. Market Share Analysis, by Country
4.4. Thoraco Lumbar
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, by Region
4.4.3. Market Share Analysis, by Country
4.5. Thoracic
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, by Region
4.5.3. Market Share Analysis, by Country
Chapter 5: Interbody Fusion Cages Market, by Surgery
5.1. Market Overview
5.1.1Market Size and Forecast, by Surgery
5.2. Anterior
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, by Region
5.2.3. Market Share Analysis, by Country
5.3. Transforaminal
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, by Region
5.3.3. Market Share Analysis, by Country
5.4. Posterior
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, by Region
5.4.3. Market Share Analysis, by Country
5.5. Lateral
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, by Region
5.5.3. Market Share Analysis, by Country
Chapter 6: Interbody Fusion Cages Market, by End-user
6.1. Market Overview
6.1.1Market Size and Forecast, by End-user
6.2. Hospitals and Clinics
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, by Region
6.2.3. Market Share Analysis, by Country
6.3. Ambulatory Surgical Centers
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, by Region
6.3.3. Market Share Analysis, by Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, by Region
6.4.3. Market Share Analysis, by Country
Chapter 7: Interbody Fusion Cages Market, by Region
7.1. Market Overview
7.1.1Market Size and Forecast, by Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, by Product
7.2.3. Market Size and Forecast, by Surgery
7.2.4. Market Size and Forecast, by End-user
7.2.5. Market Size and Forecast, by Country
7.2.6. U. S. Interbody Fusion Cages Market
7.2.6.1. Market Size and Forecast, by Product
7.2.6.2. Market Size and Forecast, by Surgery
7.2.6.3. Market Size and Forecast, by End-user
7.2.7. Canada Interbody Fusion Cages Market
7.2.7.1. Market Size and Forecast, by Product
7.2.7.2. Market Size and Forecast, by Surgery
7.2.7.3. Market Size and Forecast, by End-user
7.2.8. Mexico Interbody Fusion Cages Market
7.2.8.1. Market Size and Forecast, by Product
7.2.8.2. Market Size and Forecast, by Surgery
7.2.8.3. Market Size and Forecast, by End-user
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, by Product
7.3.3. Market Size and Forecast, by Surgery
7.3.4. Market Size and Forecast, by End-user
7.3.5. Market Size and Forecast, by Country
7.3.6. Germany Interbody Fusion Cages Market
7.3.6.1. Market Size and Forecast, by Product
7.3.6.2. Market Size and Forecast, by Surgery
7.3.6.3. Market Size and Forecast, by End-user
7.3.7. France Interbody Fusion Cages Market
7.3.7.1. Market Size and Forecast, by Product
7.3.7.2. Market Size and Forecast, by Surgery
7.3.7.3. Market Size and Forecast, by End-user
7.3.8. UK Interbody Fusion Cages Market
7.3.8.1. Market Size and Forecast, by Product
7.3.8.2. Market Size and Forecast, by Surgery
7.3.8.3. Market Size and Forecast, by End-user
7.3.9. Italy Interbody Fusion Cages Market
7.3.9.1. Market Size and Forecast, by Product
7.3.9.2. Market Size and Forecast, by Surgery
7.3.9.3. Market Size and Forecast, by End-user
7.3.10. Spain Interbody Fusion Cages Market
7.3.10.1. Market Size and Forecast, by Product
7.3.10.2. Market Size and Forecast, by Surgery
7.3.10.3. Market Size and Forecast, by End-user
7.3.11. Rest of Europe Interbody Fusion Cages Market
7.3.11.1. Market Size and Forecast, by Product
7.3.11.2. Market Size and Forecast, by Surgery
7.3.11.3. Market Size and Forecast, by End-user
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, by Product
7.4.3. Market Size and Forecast, by Surgery
7.4.4. Market Size and Forecast, by End-user
7.4.5. Market Size and Forecast, by Country
7.4.6. Japan Interbody Fusion Cages Market
7.4.6.1. Market Size and Forecast, by Product
7.4.6.2. Market Size and Forecast, by Surgery
7.4.6.3. Market Size and Forecast, by End-user
7.4.7. China Interbody Fusion Cages Market
7.4.7.1. Market Size and Forecast, by Product
7.4.7.2. Market Size and Forecast, by Surgery
7.4.7.3. Market Size and Forecast, by End-user
7.4.8. Australia Interbody Fusion Cages Market
7.4.8.1. Market Size and Forecast, by Product
7.4.8.2. Market Size and Forecast, by Surgery
7.4.8.3. Market Size and Forecast, by End-user
7.4.9. India Interbody Fusion Cages Market
7.4.9.1. Market Size and Forecast, by Product
7.4.9.2. Market Size and Forecast, by Surgery
7.4.9.3. Market Size and Forecast, by End-user
7.4.10. South Korea Interbody Fusion Cages Market
7.4.10.1. Market Size and Forecast, by Product
7.4.10.2. Market Size and Forecast, by Surgery
7.4.10.3. Market Size and Forecast, by End-user
7.4.11. Rest of Asia-Pacific Interbody Fusion Cages Market
7.4.11.1. Market Size and Forecast, by Product
7.4.11.2. Market Size and Forecast, by Surgery
7.4.11.3. Market Size and Forecast, by End-user
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, by Product
7.5.3. Market Size and Forecast, by Surgery
7.5.4. Market Size and Forecast, by End-user
7.5.5. Market Size and Forecast, by Country
7.5.6. Brazil Interbody Fusion Cages Market
7.5.6.1. Market Size and Forecast, by Product
7.5.6.2. Market Size and Forecast, by Surgery
7.5.6.3. Market Size and Forecast, by End-user
7.5.7. South Africa, Interbody Fusion Cages Market
7.5.7.1. Market Size and Forecast, by Product
7.5.7.2. Market Size and Forecast, by Surgery
7.5.7.3. Market Size and Forecast, by End-user
7.5.8. Saudi Arabia Interbody Fusion Cages Market
7.5.8.1. Market Size and Forecast, by Product
7.5.8.2. Market Size and Forecast, by Surgery
7.5.8.3. Market Size and Forecast, by End-user
7.5.9. Rest of LAMEA Interbody Fusion Cages Market
7.5.9.1. Market Size and Forecast, by Product
7.5.9.2. Market Size and Forecast, by Surgery
7.5.9.3. Market Size and Forecast, by End-user
Chapter 8: Company Profiles
8.1. Atom Medical Corporation
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Avi Healthcare Pvt. Ltd
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Equalize Heath, Inc
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. GE Healthcare
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Ibis Medical Equipment and Systems Pvt. Ltd
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Natus Medical Incorporated
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Ningbo David Medical Device Co. Ltd
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Novos Medical Devices San. Tic. Imp. And Ihr. Ltd. Sti.
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Weyer GmbH
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Zhengzhou Dison Instrument and Meter Co. Ltd
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
List of Tables
Table 1. Global Interbody Fusion Cages Market, by Product, 2020-2030 ($Million)
Table 2. Global Interbody Fusion Cages Market for Lumbar, by Region, 2020-2030 ($Million)
Table 3. Global Interbody Fusion Cages Market for Cervical, by Region, 2020-2030 ($Million)
Table 4. Global Interbody Fusion Cages Market for Thoraco Lumbar, by Region, 2020-2030 ($Million)
Table 5. Global Interbody Fusion Cages Market for Thoracic, by Region, 2020-2030 ($Million)
Table 6. Global Interbody Fusion Cages Market, by Surgery, 2020-2030 ($Million)
Table 7. Global Interbody Fusion Cages Market for Anterior, by Region, 2020-2030 ($Million)
Table 8. Global Interbody Fusion Cages Market for Transforaminal, by Region, 2020-2030 ($Million)
Table 9. Global Interbody Fusion Cages Market for Posterior, by Region, 2020-2030 ($Million)
Table 10. Global Interbody Fusion Cages Market for Lateral, by Region, 2020-2030 ($Million)
Table 11. Global Interbody Fusion Cages Market, by End-user, 2020-2030 ($Million)
Table 12. Global Interbody Fusion Cages Market for Hospitals and Clinics, by Region, 2020-2030 ($Million)
Table 13. Global Interbody Fusion Cages Market for Ambulatory Surgical Centers, by Region, 2020-2030 ($Million)
Table 14. Global Interbody Fusion Cages Market for Others, by Region, 2020-2030 ($Million)
Table 15. Global Interbody Fusion Cages Market, by Region, 2020-2030 ($Million)
Table 16. North America Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 17. North America Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 18. North America Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 19. U.S Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 20. U.S Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 21. U.S Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 22. Canada Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 23. Canada Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 24. Canada Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 25. Mexico Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 26. Mexico Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 27. Mexico Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 28. Europe Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 29. Europe Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 30. Europe Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 31. Germany Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 32. Germany Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 33. Germany Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 34. France Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 35. France Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 36. France Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 37. Uk Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 38. Uk Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 39. Uk Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 40. Italy Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 41. Italy Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 42. Italy Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 43. Spain Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 44. Spain Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 45. Spain Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 46. Rest of Europe Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 47. Rest of Europe Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 48. Rest of Europe Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 49. Asia-Pacific Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 50. Asia-Pacific Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 51. Asia-Pacific Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 52. Japan Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 53. Japan Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 54. Japan Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 55. China Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 56. China Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 57. China Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 58. Australia Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 59. Australia Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 60. Australia Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 61. India Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 62. India Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 63. India Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 64. South Korea Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 65. South Korea Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 66. South Korea Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 67. Rest of Asia-Pacific Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 68. Rest of Asia-Pacific Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 69. Rest of Asia-Pacific Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 70. Lamea Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 71. Lamea Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 72. Lamea Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 73. Brazil Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 74. Brazil Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 75. Brazil Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 76. South Africa, Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 77. South Africa, Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 78. South Africa, Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 79. Saudi Arabia Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 80. Saudi Arabia Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 81. Saudi Arabia Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 82. Rest of LAMEA Interbody Fusion Cages, by Product, 2020-2030 ($Million)
Table 83. Rest of LAMEA Interbody Fusion Cages, by Surgery, 2020-2030 ($Million)
Table 84. Rest of LAMEA Interbody Fusion Cages, by End-user, 2020-2030 ($Million)
Table 85. Atom Medical Corporation: Key Executives
Table 86. Atom Medical Corporation: Company Snapshot
Table 87. Atom Medical Corporation: Operating Segments
Table 88. Atom Medical Corporation: Product Portfolio
Table 89. Atom Medical Corporation: Key Strategic Moves and Developments
Table 90. Avi Healthcare Pvt. Ltd: Key Executives
Table 91. Avi Healthcare Pvt. Ltd: Company Snapshot
Table 92. Avi Healthcare Pvt. Ltd: Operating Segments
Table 93. Avi Healthcare Pvt. Ltd: Product Portfolio
Table 94. Avi Healthcare Pvt. Ltd: Key Strategic Moves and Developments
Table 95. Equalize Heath, Inc: Key Executives
Table 96. Equalize Heath, Inc: Company Snapshot
Table 97. Equalize Heath, Inc: Operating Segments
Table 98. Equalize Heath, Inc: Product Portfolio
Table 99. Equalize Heath, Inc: Key Strategic Moves and Developments
Table 100. Ge Healthcare: Key Executives
Table 101. Ge Healthcare: Company Snapshot
Table 102. Ge Healthcare: Operating Segments
Table 103. Ge Healthcare: Product Portfolio
Table 104. Ge Healthcare: Key Strategic Moves and Developments
Table 105. Ibis Medical Equipment and Systems Pvt. Ltd: Key Executives
Table 106. Ibis Medical Equipment and Systems Pvt. Ltd: Company Snapshot
Table 107. Ibis Medical Equipment and Systems Pvt. Ltd: Operating Segments
Table 108. Ibis Medical Equipment and Systems Pvt. Ltd: Product Portfolio
Table 109. Ibis Medical Equipment and Systems Pvt. Ltd: Key Strategic Moves and Developments
Table 110. Natus Medical Incorporated: Key Executives
Table 111. Natus Medical Incorporated: Company Snapshot
Table 112. Natus Medical Incorporated: Operating Segments
Table 113. Natus Medical Incorporated: Product Portfolio
Table 114. Natus Medical Incorporated: Key Strategic Moves and Developments
Table 115. Ningbo David Medical Device Co. Ltd: Key Executives
Table 116. Ningbo David Medical Device Co. Ltd: Company Snapshot
Table 117. Ningbo David Medical Device Co. Ltd: Operating Segments
Table 118. Ningbo David Medical Device Co. Ltd: Product Portfolio
Table 119. Ningbo David Medical Device Co. Ltd: Key Strategic Moves and Developments
Table 120. Novos Medical Devices San. Tic. Imp. And Ihr. Ltd. Sti. : Key Executives
Table 121. Novos Medical Devices San. Tic. Imp. And Ihr. Ltd. Sti. : Company Snapshot
Table 122. Novos Medical Devices San. Tic. Imp. And Ihr. Ltd. Sti. : Operating Segments
Table 123. Novos Medical Devices San. Tic. Imp. And Ihr. Ltd. Sti. : Product Portfolio
Table 124. Novos Medical Devices San. Tic. Imp. And Ihr. Ltd. Sti. : Key Strategic Moves and Developments
Table 125. Weyer Gmbh: Key Executives
Table 126. Weyer Gmbh: Company Snapshot
Table 127. Weyer Gmbh: Operating Segments
Table 128. Weyer Gmbh: Product Portfolio
Table 129. Weyer Gmbh: Key Strategic Moves and Developments
Table 130. Zhengzhou Dison Instrument and Meter Co. Ltd: Key Executives
Table 131. Zhengzhou Dison Instrument and Meter Co. Ltd: Company Snapshot
Table 132. Zhengzhou Dison Instrument and Meter Co. Ltd: Operating Segments
Table 133. Zhengzhou Dison Instrument and Meter Co. Ltd: Product Portfolio
Table 134. Zhengzhou Dison Instrument and Meter Co. Ltd: Key Strategic Moves and Developments
List of Figures
Figure 1. Global Interbody Fusion Cages Market Segmentation
Figure 2. Global Interbody Fusion Cages Market
Figure 3. Segmentation Interbody Fusion Cages Market
Figure 4. Top Investment Pocket in Interbody Fusion Cages Market
Figure 5. Top Winning Strategies, 2019-2021*
Figure 6. Top Winning Strategies, by Development, 2019-2021(%)
Figure 7. Top Winning Strategies, by Company, 2019-2021*
Figure 8. Moderate Bargaining Power of Buyers
Figure 9. Moderate Bargaining Power of Suppliers
Figure 10. Moderate Threat of New Entrants
Figure 11. Low Threat of Substitution
Figure 12. High Competitive Rivalry
Figure 13. Top Player Positioning, 2020
Figure 14. Market Share Analysis, 2020
Figure 15. Restraints and Drivers: Interbody Fusion Cages Market
Figure 16. Interbody Fusion Cages Market Segmentation, by Product
Figure 17. Interbody Fusion Cages Market for Lumbar, by Country, 2020-2030 ($ Million)
Figure 18. Interbody Fusion Cages Market for Cervical, by Country, 2020-2030 ($ Million)
Figure 19. Interbody Fusion Cages Market for Thoraco Lumbar, by Country, 2020-2030 ($ Million)
Figure 20. Interbody Fusion Cages Market for Thoracic, by Country, 2020-2030 ($ Million)
Figure 21. Interbody Fusion Cages Market Segmentation, by Surgery
Figure 22. Interbody Fusion Cages Market for Anterior, by Country, 2020-2030 ($ Million)
Figure 23. Interbody Fusion Cages Market for Transforaminal, by Country, 2020-2030 ($ Million)
Figure 24. Interbody Fusion Cages Market for Posterior, by Country, 2020-2030 ($ Million)
Figure 25. Interbody Fusion Cages Market for Lateral, by Country, 2020-2030 ($ Million)
Figure 26. Interbody Fusion Cages Market Segmentation, by End-user
Figure 27. Interbody Fusion Cages Market for Hospitals and Clinics, by Country, 2020-2030 ($ Million)
Figure 28. Interbody Fusion Cages Market for Ambulatory Surgical Centers, by Country, 2020-2030 ($ Million)
Figure 29. Interbody Fusion Cages Market for Others, by Country, 2020-2030 ($ Million)
Figure 30. Atom Medical Corporation: Net Sales, 2018-2020 ($ Million)
Figure 31. Atom Medical Corporation: Revenue Share, by Segment, 2020 (%)
Figure 32. Atom Medical Corporation: Revenue Share, by Region, 2020 (%)
Figure 33. Avi Healthcare Pvt. Ltd: Net Sales, 2018-2020 ($ Million)
Figure 34. Avi Healthcare Pvt. Ltd: Revenue Share, by Segment, 2020 (%)
Figure 35. Avi Healthcare Pvt. Ltd: Revenue Share, by Region, 2020 (%)
Figure 36. Equalize Heath, Inc: Net Sales, 2018-2020 ($ Million)
Figure 37. Equalize Heath, Inc: Revenue Share, by Segment, 2020 (%)
Figure 38. Equalize Heath, Inc: Revenue Share, by Region, 2020 (%)
Figure 39. Ge Healthcare: Net Sales, 2018-2020 ($ Million)
Figure 40. Ge Healthcare: Revenue Share, by Segment, 2020 (%)
Figure 41. Ge Healthcare: Revenue Share, by Region, 2020 (%)
Figure 42. Ibis Medical Equipment and Systems Pvt. Ltd: Net Sales, 2018-2020 ($ Million)
Figure 43. Ibis Medical Equipment and Systems Pvt. Ltd: Revenue Share, by Segment, 2020 (%)
Figure 44. Ibis Medical Equipment and Systems Pvt. Ltd: Revenue Share, by Region, 2020 (%)
Figure 45. Natus Medical Incorporated: Net Sales, 2018-2020 ($ Million)
Figure 46. Natus Medical Incorporated: Revenue Share, by Segment, 2020 (%)
Figure 47. Natus Medical Incorporated: Revenue Share, by Region, 2020 (%)
Figure 48. Ningbo David Medical Device Co. Ltd: Net Sales, 2018-2020 ($ Million)
Figure 49. Ningbo David Medical Device Co. Ltd: Revenue Share, by Segment, 2020 (%)
Figure 50. Ningbo David Medical Device Co. Ltd: Revenue Share, by Region, 2020 (%)
Figure 51. Novos Medical Devices San. Tic. Imp. And Ihr. Ltd. Sti: Net Sales, 2018-2020 ($ Million)
Figure 52. Novos Medical Devices San. Tic. Imp. And Ihr. Ltd. Sti: Revenue Share, by Segment, 2020 (%)
Figure 53. Novos Medical Devices San. Tic. Imp. And Ihr. Ltd. Sti: Revenue Share, by Region, 2020 (%)
Figure 54. Weyer Gmbh: Net Sales, 2018-2020 ($ Million)
Figure 55. Weyer Gmbh: Revenue Share, by Segment, 2020 (%)
Figure 56. Weyer Gmbh: Revenue Share, by Region, 2020 (%)
Figure 57. Zhengzhou Dison Instrument and Meter Co. Ltd: Net Sales, 2018-2020 ($ Million)
Figure 58. Zhengzhou Dison Instrument and Meter Co. Ltd: Revenue Share, by Segment, 2020 (%)
Figure 59. Zhengzhou Dison Instrument and Meter Co. Ltd: Revenue Share, by Region, 2020 (%)

Executive Summary

According to a new report titled, “Interbody Fusion Cage Market, by Product Type, Surgery, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030,” the global interbody fusion cages market size was valued at $1,901.67 million in 2020, and is projected to reach $3,012.47 million by 2030, registering a CAGR of 4.7% from 2021 to 2030.

Interbody fusion cage is an artificial medical device, which is utilized in spinal fusion procedures to maintain foraminal height and decompression. The interbody fusion cage is a large, hollow cylinder made up of metals such as titanium, carbon fiber, or allograft femur. The device is designed as a cage so that bone graft can be placed inside the hollow cylinder to allow a spinal fusion to occur between two vertebrae. Interbody fusion cage utilized to provide stability to the spine and the cervical region. The cages can be filled with autologous bone material to promote arthrodesis (artificial induction of joint ossification).

The growth of the Interbody fusion cages market is majorly driven by increased in demand for interbody fusion cage surgeries due to advantages that allow the surgeon to directly decompress nerves and reconstruct the spine. The key factors further driving the market growth are increase in geriatric population and surge in cases of spinal cord injuries, which might be caused due to accidents and diseases such as degenerative disk disease. In addition, upsurge in disposable income in the developing economies such as India and China contributes toward the growth of the market. However, high cost associated with spinal fusion surgeries, lack of skilled professionals, and increase in disposable incomes in emerging economies restrain the Interbody fusion cages market growth.

On the basis of product type, the lumbar cage segment was the major revenue contributor in 2020, and is anticipated to continue this trend during the forecast period, owing to increase in cervical fusion surgeries, which preserve the motion of the spine, do not need bone grafting & cervical disc replacement, and do not require a plate be placed directly in the front of the spine. On the other side, the thoracic cage segment is projected to exhibit the fastest market growth during the forecast period, owing to rise in use of thoracic cage.

On the basis of surgery, the anterior segment presently dominates the Interbody fusion cages market, and is expected to remain dominant during the forecast period, owing to ease in accessing the body from the front section.

On the basis of end user, the hospital segment presently dominates the market, and is expected to remain dominant during the forecast period, owing to increase number of spinal fusion performed at hospitals. Growing government initiatives to improve the healthcare infrastructure and expanding the middle-class population in developing nations such as India are resulting in increasing demand for quality healthcare services delivered by hospitals, thereby aiding segment growth.

North America dominated the global Interbody fusion cages market in 2020, and is expected to remain dominant throughout the forecast period with a CAGR of 3.9%. Owing to increase in geriatric population, surge in prevalence of spinal disorders, and rise in incidence of sports injuries and fatal accidents are among key factors boosting the demand for interbody fusion cage devices in North America. In addition, the presence of well-established healthcare infrastructure is expected to propel market growth in the region. Asia-Pacific is projected to register the highest CAGR of 6.0% during the forecast period, owing to its high population base and significant increase in spinal injuries.

In addition, surge in medical tourism, growth in disposable income, and rise in awareness among patients toward advanced interbody fusion devices boost the market growth in this region. Moreover, the medical device companies such as Titan Spine, Inc., and K2M have penetrated Asia-Pacific and launched several interbody fusion devices.

The major companies profiled in the Interbody fusion cages market report include Aurora Spine, Inc, B. Braun Melsungen AG, Benvenue Medical Inc., Prodorth, Ulrich Medicals, Orthofix, Medtronic Plc, Zimmer Biomet Holdings, Inc., NuVasive, Inc., and Johnson & Johnson.

Key Findings Of The Study


By product type, the lumbar cage segment is expected to experience rapid growth in the Interbody fusion cages market, and is projected to grow at a CAGR of 3.8% from 2021 to 2030
  • Thoracic cage is projected to grow at a CAGR of 66% during the forecast period
  • Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 60% during the forecast period

Companies Mentioned

  • Aurora Spine, Inc.
  • B. Braun Melsungen AG
  • Benvenue Medical Inc.
  • Prodorth
  • Ulrich Medicals
  • Orthofix
  • Medtronic Plc
  • Zimmer Biomet Holdings, Inc.
  • NuVasive, Inc.
  • Johnson & Johnson.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information